Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity

This publication has 69 references indexed in Scilit:

• Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments
  European Journal of Immunology, 2002
• Monomeric Recombinant MD-2 Binds Toll-like Receptor 4 Tightly and Confers Lipopolysaccharide Responsiveness
  Published by Elsevier ,2002
• Toll-like Receptor 2 and 4 (TLR2 and TLR4) Agonists Differentially Regulate Secretory Interleukin-1 Receptor Antagonist Gene Expression in Macrophages
  Published by Elsevier ,2002
• Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
  Nature Immunology, 2002
• The Mannose Receptor, a Bi-Functional Lectin with Roles in Homeostasis and Immunity.
  Trends in Glycoscience and Glycotechnology, 2002
• Lipopolysaccharide Is in Close Proximity to Each of the Proteins in Its Membrane Receptor Complex
  Journal of Biological Chemistry, 2001
• Adjuvants—a classification and review of their modes of action
  Published by Elsevier ,1998
• Covalent chemical events in immune induction: fundamental and therapeutic aspects
  Immunology Today, 1996
• Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function
  Vaccine, 1995
• Accessory Cell Requirements for Saponin Adjuvant-Induced Class I MHC Antigen-Restricted Cytotoxic T-Lymphocytes
  Cellular Immunology, 1994